Latest Breaking News On - Application covering - Page 2 : vimarsana.com

Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U S Patent Application Covering PKU GOLIKE(R)

Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R) 27-Apr-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR.

Switzerland generalUnited statesPaolo galfettiMichael millerJack weinsteinAdvita lifescience gmbRelief therapeutics holding sa keyPharma researchSwiss exchangeRx communications groupPhysiomimic technologyTrademark officePhysiomimic tm technologyRelief therapeutics holdingNews serviceNeurorx inc

Investegate |Relief Therapeutics Holding SA Announcements | Relief Therapeutics Holding SA: Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U S Patent Application Covering PKU GOLIKE(R)

Investegate |Relief Therapeutics Holding SA Announcements | Relief Therapeutics Holding SA: Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U S Patent Application Covering PKU GOLIKE(R)
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United statesPaolo galfettiMichael millerJack weinsteinAdvita lifescience gmbPharma researchSwiss exchangeRx communications groupPhysiomimic technologyTrademark officePhysiomimic tm technologyNeurorx incRelief therapeutic wholly owned subsidiaryReceives noticeApplication coveringPatent application

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Acer Therapeutics Receives Notice of Allowance of Key U S Patent Application Covering ACER-001 Formulation

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00

University of washingtonUnited statesJim denikeMichael millerHans vitzthumJeff davisJack weinsteinAdvita lifescience gmbEuropean patent officeStock exchangeRx communications groupHolding ag keyTrademark officeAcer therapeutics incDrug administrationPharma research

EQS-Adhoc: Acer Therapeutics Receives Notice of Allowance of Key U S Patent Application Covering ACER-001 Formulation

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsibl.

University of washingtonUnited statesJim denikeMichael millerHans vitzthumJeff davisJack weinsteinAdvita lifescience gmbEuropean patent officeStock exchangeRx communications groupHolding ag keyTrademark officeAcer therapeutics incDrug administrationPharma research